Labmanager Logo

BioTek Introduces the Eon™ High Performance Microplate Spectrophotometer

BioTek's new monochromator-based Eon™ Microplate Spectrophotometer

| 1 min read
Share this Article
Register for free to listen to this article
Listen with Speechify
0:00
1:00

July 7, 2011, WINOOSKI VT, USA — BioTek's new monochromator-based Eon™ Microplate Spectrophotometer combines high performance and high value in microplate-based absorbance readings. Like BioTek's popular Epoch™ Microplate Spectrophotometer, Eon's monochromator-based optics allow flexible, filter-free 200-999 nm wavelength selection in 1 nm increments, and spectral scanning for 6- to 384-well microplates. An optional cuvette port expands functionality to cuvette-based assays and also aids in assay miniaturization to microplates or the 2 µL volumes used with BioTek's Take3™ and new Take3 Trio Micro-Volume Plates.

Additional features include superior 4-Zone™ temperature control with incubation up to 65°C, and walk-away automation when paired with BioTek's BioStack™ Microplate Stacker or third-party robotics. Linear, orbital and double orbital shake modes are customizable for easy assay optimization in biofuel research, cell proliferation, cytotoxicity studies and many more applications.

Eon is powered by the new Gen5™ 2.0 Data Analysis Software for intuitive reader control and unsurpassed data analysis. Flexible and customizable data export includes publication-ready reports, Microsoft® Excel® spreadsheets and output to LIMS/LIS.

Want the latest lab management news?

Subscribe to our free Lab Manager Monitor newsletter.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.

For further information, contact:
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications
908-818-9463
cgriffin@shawtodd.com

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - December 2024

2025 Industry and Equipment Trends

Purchasing trends survey results

Lab Manager December 2024 Cover Image
Lab Manager eNewsletter

Stay Connected

Click below to subscribe to Lab Manager Monitor eNewsletter!

Subscribe Today